vs
Side-by-side financial comparison of ADAMAS TRUST, INC. (ADAM) and GRAIL, Inc. (GRAL). Click either name above to swap in a different company.
GRAIL, Inc. is the larger business by last-quarter revenue ($43.6M vs $43.2M, roughly 1.0× ADAMAS TRUST, INC.). ADAMAS TRUST, INC. runs the higher net margin — 124.0% vs -227.5%, a 351.5% gap on every dollar of revenue. On growth, ADAMAS TRUST, INC. posted the faster year-over-year revenue change (61.6% vs 14.0%). ADAMAS TRUST, INC. produced more free cash flow last quarter ($125.9M vs $-63.9M). Over the past eight quarters, ADAMAS TRUST, INC.'s revenue compounded faster (55.5% CAGR vs 27.7%).
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.
ADAM vs GRAL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $43.2M | $43.6M |
| Net Profit | $53.5M | $-99.2M |
| Gross Margin | — | — |
| Operating Margin | — | -285.4% |
| Net Margin | 124.0% | -227.5% |
| Revenue YoY | 61.6% | 14.0% |
| Net Profit YoY | 270.5% | -2.2% |
| EPS (diluted) | $0.45 | $-2.37 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $43.2M | $43.6M | ||
| Q3 25 | $36.6M | $36.2M | ||
| Q2 25 | $36.4M | $35.5M | ||
| Q1 25 | $33.1M | $31.8M | ||
| Q4 24 | $26.7M | $38.3M | ||
| Q3 24 | $20.2M | $28.7M | ||
| Q2 24 | $19.0M | $32.0M | ||
| Q1 24 | $17.9M | $26.7M |
| Q4 25 | $53.5M | $-99.2M | ||
| Q3 25 | $44.8M | $-89.0M | ||
| Q2 25 | $8.5M | $-114.0M | ||
| Q1 25 | $42.2M | $-106.2M | ||
| Q4 24 | $-31.4M | $-97.1M | ||
| Q3 24 | $42.8M | $-125.7M | ||
| Q2 24 | $-15.6M | $-1.6B | ||
| Q1 24 | $-57.9M | $-218.9M |
| Q4 25 | — | -285.4% | ||
| Q3 25 | — | -346.2% | ||
| Q2 25 | 11.7% | -446.9% | ||
| Q1 25 | — | -482.5% | ||
| Q4 24 | -119.0% | -358.0% | ||
| Q3 24 | — | -640.5% | ||
| Q2 24 | -124.7% | -5133.8% | ||
| Q1 24 | -448.8% | -851.1% |
| Q4 25 | 124.0% | -227.5% | ||
| Q3 25 | 122.5% | -245.8% | ||
| Q2 25 | 23.4% | -320.7% | ||
| Q1 25 | 127.4% | -333.6% | ||
| Q4 24 | -117.5% | -253.8% | ||
| Q3 24 | 211.7% | -438.7% | ||
| Q2 24 | -81.9% | -4958.8% | ||
| Q1 24 | -324.1% | -819.3% |
| Q4 25 | $0.45 | $-2.37 | ||
| Q3 25 | $0.36 | $-2.46 | ||
| Q2 25 | $-0.04 | $-3.18 | ||
| Q1 25 | $0.33 | $-3.10 | ||
| Q4 24 | $-0.46 | $-1.49 | ||
| Q3 24 | $0.36 | $-3.94 | ||
| Q2 24 | $-0.29 | $-51.06 | ||
| Q1 24 | $-0.75 | $-7.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $210.3M | $249.7M |
| Total DebtLower is stronger | $735.8M | — |
| Stockholders' EquityBook value | $1.4B | $2.6B |
| Total Assets | $12.6B | $2.9B |
| Debt / EquityLower = less leverage | 0.52× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $210.3M | $249.7M | ||
| Q3 25 | $185.3M | $126.9M | ||
| Q2 25 | $160.4M | $127.4M | ||
| Q1 25 | $177.1M | $133.9M | ||
| Q4 24 | $167.4M | $214.2M | ||
| Q3 24 | $195.1M | $853.6M | ||
| Q2 24 | $235.5M | $958.8M | ||
| Q1 24 | $226.9M | $199.7M |
| Q4 25 | $735.8M | — | ||
| Q3 25 | $766.6M | — | ||
| Q2 25 | $653.0M | — | ||
| Q1 25 | $654.4M | — | ||
| Q4 24 | $573.2M | — | ||
| Q3 24 | $699.4M | — | ||
| Q2 24 | $800.7M | — | ||
| Q1 24 | $1.0B | — |
| Q4 25 | $1.4B | $2.6B | ||
| Q3 25 | $1.4B | $2.2B | ||
| Q2 25 | $1.4B | $2.3B | ||
| Q1 25 | $1.4B | $2.4B | ||
| Q4 24 | $1.4B | $2.5B | ||
| Q3 24 | $1.4B | $2.6B | ||
| Q2 24 | $1.4B | $2.7B | ||
| Q1 24 | $1.5B | — |
| Q4 25 | $12.6B | $2.9B | ||
| Q3 25 | $12.4B | $2.6B | ||
| Q2 25 | $10.6B | $2.7B | ||
| Q1 25 | $10.0B | $2.8B | ||
| Q4 24 | $9.2B | $3.0B | ||
| Q3 24 | $8.9B | $3.1B | ||
| Q2 24 | $8.2B | $3.3B | ||
| Q1 24 | $7.4B | — |
| Q4 25 | 0.52× | — | ||
| Q3 25 | 0.55× | — | ||
| Q2 25 | 0.47× | — | ||
| Q1 25 | 0.47× | — | ||
| Q4 24 | 0.41× | — | ||
| Q3 24 | 0.48× | — | ||
| Q2 24 | 0.56× | — | ||
| Q1 24 | 0.67× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $134.0M | $-63.8M |
| Free Cash FlowOCF − Capex | $125.9M | $-63.9M |
| FCF MarginFCF / Revenue | 291.6% | -146.5% |
| Capex IntensityCapex / Revenue | 18.9% | 0.2% |
| Cash ConversionOCF / Net Profit | 2.50× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-299.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $134.0M | $-63.8M | ||
| Q3 25 | $6.9M | $-63.2M | ||
| Q2 25 | $39.2M | $-77.0M | ||
| Q1 25 | $25.8M | $-95.0M | ||
| Q4 24 | $14.1M | — | ||
| Q3 24 | $-922.0K | $-104.6M | ||
| Q2 24 | $-993.0K | $-171.8M | ||
| Q1 24 | $-13.1M | $-207.3M |
| Q4 25 | $125.9M | $-63.9M | ||
| Q3 25 | — | $-63.6M | ||
| Q2 25 | — | $-77.3M | ||
| Q1 25 | — | $-95.1M | ||
| Q4 24 | $-10.6M | — | ||
| Q3 24 | $-8.6M | $-105.6M | ||
| Q2 24 | $-8.6M | $-173.2M | ||
| Q1 24 | $-19.1M | $-209.8M |
| Q4 25 | 291.6% | -146.5% | ||
| Q3 25 | — | -175.8% | ||
| Q2 25 | — | -217.6% | ||
| Q1 25 | — | -298.6% | ||
| Q4 24 | -39.6% | — | ||
| Q3 24 | -42.3% | -368.4% | ||
| Q2 24 | -44.9% | -541.7% | ||
| Q1 24 | -107.0% | -785.3% |
| Q4 25 | 18.9% | 0.2% | ||
| Q3 25 | — | 1.1% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | 92.3% | — | ||
| Q3 24 | 37.7% | 3.4% | ||
| Q2 24 | 39.7% | 4.3% | ||
| Q1 24 | 33.5% | 9.5% |
| Q4 25 | 2.50× | — | ||
| Q3 25 | 0.15× | — | ||
| Q2 25 | 4.59× | — | ||
| Q1 25 | 0.61× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.02× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ADAM
| Other | $19.6M | 45% |
| Constructive Loans LLC | $14.4M | 33% |
| Multifamily | $9.1M | 21% |
GRAL
| Screening Revenue | $42.3M | 97% |
| Developmental Services Revenue | $1.3M | 3% |
